首页> 外文期刊>International journal of oral science >Local icariin application enhanced periodontal tissue regeneration and relieved local inflammation in a minipig model of periodontitis
【24h】

Local icariin application enhanced periodontal tissue regeneration and relieved local inflammation in a minipig model of periodontitis

机译:在微型猪的牙周炎模型中,局部叶黄素的应用增强了牙周组织的再生并减轻了局部炎症

获取原文
       

摘要

Periodontitis is an inflammatory autoimmune disease. Treatment should alleviate inflammation, regulate the immune reaction and promote periodontal tissue regeneration. Icariin is the main active ingredient of Epimedii Folium, and it is a promising compound for the enhancement of mesenchymal stem cell function, promotion of bone formation, inhibition of bone resorption, alleviation of inflammation and regulation of immunity. The study investigated the effect of icariin on periodontal tissue regeneration in a minipig model of periodontitis. The minipig model of periodontitis was established. Icariin was injected locally. The periodontal clinical assessment index, a computed tomography (CT) scan, histopathology and enzyme-linked immune sorbent assay (ELISA) were used to evaluate the effects of icariin. Quantitative analysis results 12 weeks post-injection demonstrated that probing depth, gingival recession, attachment loss and alveolar bone regeneration values were (3.72?±?1.18)?mm vs. (6.56?±?1.47)?mm, (1.67?±?0.59)?mm vs. (2.38?±?0.61)?mm, (5.56?±?1.29)?mm vs. (8.61?±?1.72)?mm, and (25.65?±?5.13)?mm~(3)vs. (9.48?±?1.78) mm~(3)in the icariin group and 0.9% NaCl group, respectively. The clinical assessment, CT scan, and histopathology results demonstrated significant enhancement of periodontal tissue regeneration in the icariin group compared to the 0.9% NaCl group. The ELISA results suggested that the concentration of interleukin-1 beta (IL-1β) in the icariin group was downregulated compared to the 0.9% NaCl group, which indicates that local injection of icariin relieved local inflammation in a minipig model of periodontitis. Local injection of icariin promoted periodontal tissue regeneration and exerted anti-inflammatory and immunomodulatory function. These results support the application of icariin for the clinical treatment of periodontitis. Treating periodontitis with Chinese herbal injection A Chinese herbal supplement could treat an inflammatory autoimmune disease of the tissues surrounding the teeth. Zhipeng Fan and colleagues at Capital Medical University in Beijing, China found reduced inflammation and improved tissue regeneration in induced periodontitis in miniature pigs, three months following local injections with the Chinese herbal extract icariin. Periodontitis is an overactive immune response to bacterial invasion in the gums, leading to the breakdown of supportive tissue and bone, and potential tooth loss. Clinical assessment, CT scans and microscopic examination showed icariin injections promoted gum and bone regeneration, possibly by stimulating local stem cells. It also reduced signs of inflammation, including significantly decreasing the expression of IL-1β, an immune response mediator. Further studies are needed to confirm icariin’s mode of action and optimal dosage for potential clinical use.
机译:牙周炎是一种炎症性自身免疫性疾病。治疗应减轻炎症,调节免疫反应并促进牙周组织再生。鹰嘴豆素是淫羊Epi的主要活性成分,是增强间充质干细胞功能,促进骨形成,抑制骨吸收,减轻炎症和调节免疫力的有前途的化合物。该研究在小型猪牙周炎模型中研究了蓖麻油苷对牙周组织再生的影响。建立了牙周炎的小型猪模型。伊卡林是局部注射的。使用牙周临床评估指标,计算机断层扫描(CT)扫描,组织病理学和酶联免疫吸附测定(ELISA)来评估icariin的效果。注射后12周的定量分析结果表明,探查深度,牙龈退缩,附着力丧失和牙槽骨再生值分别为(3.72?±?1.18)?mm和(6.56?±?1.47)?mm,(1.67?±?)。 0.59)?mm与(2.38?±?0.61)?mm,(5.56?±?1.29)?mm与(8.61?±?1.72)?mm和(25.65?±?5.13)?mm〜(3 )。大麻素组和0.9%NaCl组分别为(9.48±±1.78)mm〜(3)。临床评估,CT扫描和组织病理学结果表明,与0.9%NaCl组相比,二十碳黄素组的牙周组织再生显着增强。 ELISA结果表明,与0.9%NaCl组相比,icariin组中的IL-1β(IL-1β)浓度被下调,这表明局部注射icariin可减轻牙周炎小型猪模型中的局部炎症。局部注射icariin可促进牙周组织再生并发挥抗炎和免疫调节功能。这些结果支持了icariin在牙周炎临床治疗中的应用。用中草药注射剂治疗牙周炎中草药补充剂可以治疗牙齿周围组织的炎性自身免疫病。中国北京首都医科​​大学的范志鹏及其同事发现,局部注射中草药提取物苦瓜素后三个月,小型猪诱发的牙周炎的炎症减轻,组织再生得到改善。牙周炎是对牙龈中细菌入侵的过度活跃的免疫反应,导致支持性组织和骨骼的破裂以及潜在的牙齿脱落。临床评估,CT扫描和显微镜检查显示,注射大麻素可能通过刺激局部干细胞促进了牙龈和骨骼的再生。它还减少了炎症迹象,包括显着降低了免疫应答介质IL-1β的表达。需要进行进一步的研究,以确认大麻素的作用方式和最佳剂量,以用于潜在的临床用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号